bilaterals.org logo
bilaterals.org logo

intellectual property


Development and intellectual property under the EPA negotiations
This South Centre policy brief examines the approach under the ongoing EPA negotiations with respect to innovation, biodiversity and traditional knowledge, public health, Least Developed Countries and on enforcement of intellectual property rights. It concludes that considering the level of economic development in ACP countries, the negotiations should not include IP rights as part of the partnership agreement.
Intellectual property, bilateral agreements and sustainable development: A strategy note
This paper addresses the main threats of the intellectual property chapters in the bilateral and regional agreements with the US for access to medicines, give an overview of the reactions from different sectors to these agreements, and outline some strategic considerations for future action.
The European approach to intellectual property in European Partnership Agreements with the ACP countries
A CIEL discussion paper on the European Union’s attempts to impose TRIPS-plus standards on 76 African, Caribbean and Pacific countries
FTA: Malaysia imposes terms on data exclusivity for US pharmaceuticals
Malaysia has set some conditions in agreeing to the U.S. request for data exclusivity (DE) for new pharmaceutical products in the bilateral free trade agreement (FTA) negotiations, Health Minister Datuk Seri Dr Chua Soi Lek said today.
‘Piracy blocks foreign investment’
President Karachi Chamber of Commerce and Industry Majyd Aziz has called for creating awareness of intellectual property rights and effective enforcement of IPR legislation in order to attract investment in the country.
Colombian study on impact of US FTA on medicine
This is an English translation of a full study done in Colombia of the impacts of its US free trade agreement (FTA) on medicine consumption and the Colombian generic industry. The study study used the World Health Organization’s methodology.
Japan trade frays tempers
Opponents of the draft Japan-Thailand Economic Partnership Agreement (JTEPA) have asserted that the Surayud Chulanont government needs to take two controversial issues in the pact seriously.
Facts and evidences on the 10 burning issues related to the government use of patents on three patented essential drugs in Thailand
The recent decisions of the Thai Ministry of Public Health to announce the Government Use of Patents on three patented drugs, i.e., Efavirenz (Stocrin®) of Merck Sharp and Dohme), Lopinavir+Ritonavir (Kaletra®) of Abbott Laboratory) and Clopidogrel (Plavix®) of Sanofi-Aventis), based on proposals from the National Health Security Office, have raised several questions among the public and also the concerned partners as well as the pharmaceutical industries, both in the country and internationally.
High standards of IP protection in MUFTA attracts FDI
Malaysia is currently in negotiations with the United States for a Free Trade Agreement (MUFTA) which is expected to ease the way for attracting more foreign direct investment to Malaysia. Amongst the issues being negotiated is the strengthening of intellectual property rights (IPR) in Malaysia.
Too big a price to pay for an FTA
Letter from the Malaysian Organisation of Pharmaceutical Industries contesting the American Malaysian Chamber of Commerce’s claim that that the country’s generic medicine manufacturers will do better if the Malaysia-US free trade agreement is signed.
No renegotiation on Thai-Japan trade deal
Thai Foreign Minister Nitya Pibulsonggram told a powerful Japanese business association on Monday that Thailand would not renegotiate on any issues in the controversial economic agreement with Japan.
Govt orders more FTA talks
The Thai cabinet yesterday instructed officials negotiating the Thai-Japanese Free Trade Agreement not to sign any deal without further talks with Tokyo to clear the air on issues like toxic waste imports and the patenting of micro-organisms.
NGOs fear there’s a hidden agenda in Japan FTA
Khao-Kwan Foundation chairman Day-cha Siripatra said the country would lose several hundred billion baht a year if the government allowed Japan to patent micro-organisms.
KoA No FTA Newsletter #2
Farmers release animals in protest, 500 attend all-night vigil; KoA protest delegation holds all-night vigil, congressional briefing in DC; Limiting access to healthcare: FTA and pharmaceuticals
Questions over FTA with the US
Will the bilateral free trade agreement between Malaysia and the US be signed?
NLA lobbied hard to back FTA deal with Japan
The Thai Foreign Ministry is lobbying hard for the National Legislative Assembly’s support for a free trade area (FTA) agreement with Japan
India in free trade talks with four European countries
India is in talks with four European countries - Switzerland, Norway, Iceland and Liechtenstein - to strike a comprehensive economic agreement that would facilitate free trade relations. Switzerland is also trying to set up a working group with India on intellectual property rights and also seeking to enhance cooperation in science and technology fields.
Not under the same sky: bilateral free trade agreements (FTAs), agriculture and food sovereignty
An initial report on the spread of Free Trade Agreements (FTAs) throughout the Asia-Pacific and their impacts on agriculture and food sovereignty, in the context of the current state of play of the WTO, and the devastating legacy of agricultural liberalisation through World Bank/International Monetary Fund structural adjustment programmes.
Activists want waste provisions to be removed from agreement
Activists have called on Thailand’s National Legislative Assembly to remove trade in waste and micro-organism patenting from the Japan-Thailand Free Trade Agreement (FTA).
Intellectual property, bilateral agreements and sustainable development: The challenges of implementation
What appears to be the experience of countries that have negotiated FTAs is that the process of negotiations does not conclude with the signing of the agreement. The implementation process is a complex and tedious one. In addition, once this implementation phase has been concluded, a subsequent and difficult phase begins with the monitoring of this implementation.